Bioxcel TherapeuticsEquity-NMS: BTAI
Equity-NMS: BTAI
$0.37
+0.01
(26 Dec)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$0.37
Open
$0.37
Today’s high
$0.40
Today’s low
$0.33
52W low
$0.30
52W high
$4.17
1Y
-87.72%
5Y
-48.20%
EPS (TTM)
-2.04
Shares O/S
48.35M
Market cap
17.89M
Insights
BTAI has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.
BTAI price is below its 200 day moving average
BTAI is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Bioxcel Therapeutics

BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation associated with psychiatric and neurological disorders.

It is continuing to develop BXCL501 for the potential acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home setting and for the potential acute treatment of agitation (non-daily) associated with dementia due to probable Alzheimers disease in the at-home setting and in care facilities. Its most advanced immuno-oncology candidate, BXCL701, is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. .


FAQs

Can I buy Bioxcel Therapeutics shares in India?
How to buy Bioxcel Therapeutics shares in India?
What is the share price of Bioxcel Therapeutics?
What is the Market Capitalization of Bioxcel Therapeutics?
What is the PE ratio of Bioxcel Therapeutics?
Is Bioxcel Therapeutics a good stock to buy?
In which sector / industry does Bioxcel Therapeutics operate?